Obesity is associated with macrophage accumulation in adipose tissue.

Obesity alters adipose tissue metabolic and endocrine function and leads to an increased release of fatty acids, hormones, and proinflammatory molecules that contribute to obesity associated complications. To further characterize the changes that occur in adipose tissue with increasing adiposity, we profiled transcript expression in perigonadal adipose tissue from groups of mice in which adiposity varied due to sex, diet, and the obesity-related mutations agouti (Ay) and obese (Lepob). We found that the expression of 1,304 transcripts correlated significantly with body mass. Of the 100 most significantly correlated genes, 30% encoded proteins that are characteristic of macrophages and are positively correlated with body mass. Immunohistochemical analysis of perigonadal, perirenal, mesenteric, and subcutaneous adipose tissue revealed that the percentage of cells expressing the macrophage marker F4/80 (F4/80+) was significantly and positively correlated with both adipocyte size and body mass. Similar relationships were found in human subcutaneous adipose tissue stained for the macrophage antigen CD68. Bone marrow transplant studies and quantitation of macrophage number in adipose tissue from macrophage-deficient (Csf1op/op) mice suggest that these F4/80+ cells are CSF-1 dependent, bone marrow-derived adipose tissue macrophages. Expression analysis of macrophage and nonmacrophage cell populations isolated from adipose tissue demonstrates that adipose tissue macrophages are responsible for almost all adipose tissue TNF-alpha expression and significant amounts of iNOS and IL-6 expression. Adipose tissue macrophage numbers increase in obesity and participate in inflammatory pathways that are activated in adipose tissues of obese individuals.

[1]  E. Stanley,et al.  Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. , 2004, Blood.

[2]  S. Heymsfield,et al.  Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  J. Tordjman,et al.  Thiazolidinediones Block Fatty Acid Release by Inducing Glyceroneogenesis in Fat Cells* , 2003, Journal of Biological Chemistry.

[4]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[6]  D. Grobbee,et al.  Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. , 2003, The American journal of clinical nutrition.

[7]  Mireille André,et al.  Preadipocyte Conversion to Macrophage , 2003, The Journal of Biological Chemistry.

[8]  M. Pandey,et al.  Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1. , 2003, The American journal of pathology.

[9]  S. Bahouth,et al.  Resistin release by human adipose tissue explants in primary culture. , 2003, Biochemical and biophysical research communications.

[10]  Nancy R Cook,et al.  Body mass index and the risk of stroke in men. , 2002, Archives of internal medicine.

[11]  D. Slonim.  From patterns to pathways: gene expression data analysis comes of age , 2002, Nature Genetics.

[12]  H. Lodish,et al.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Pergola,et al.  Coagulation and fibrinolysis abnormalities in obesity , 2002, Journal of endocrinological investigation.

[14]  Robert Ross,et al.  Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. , 2002, Archives of internal medicine.

[15]  V. Manganiello,et al.  Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. , 2002, Diabetes.

[16]  R. Evans,et al.  Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis , 2002, Trends in Endocrinology & Metabolism.

[17]  M. Lazar,et al.  A futile metabolic cycle activated in adipocytes by antidiabetic agents , 2002, Nature Medicine.

[18]  David E. Misek,et al.  Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte Metabolism , 2002, Molecular and Cellular Biology.

[19]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[20]  I. Kullo,et al.  Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, > or =30). , 2002, The American journal of cardiology.

[21]  S. Heymsfield,et al.  Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. , 2002, The Journal of clinical endocrinology and metabolism.

[22]  M. Washington,et al.  Macrophages Are Necessary for Maximal Nuclear Factor- κ B Activation in Response to Endotoxin , 2002 .

[23]  R. Westrick,et al.  Effect of leptin on arterial thrombosis following vascular injury in mice. , 2002, JAMA.

[24]  P. Crowe,et al.  Regulation of murine macrophage proinflammatory and anti‐inflammatory cytokines by ligands for peroxisome proliferator‐activated receptor‐γ: counter‐regulatory activity by IFN‐γ , 2002, Journal of Leukocyte Biology.

[25]  C. Stehouwer,et al.  Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. , 2002, Atherosclerosis.

[26]  L. Rossetti,et al.  Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. , 2001, The Journal of clinical investigation.

[27]  A. Marette,et al.  Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle , 2001, Nature Medicine.

[28]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[29]  T. Ochi,et al.  Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines , 2001, Arthritis research.

[30]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[31]  P. Ferré,et al.  Cholesterol, a Cell Size-dependent Signal That Regulates Glucose Metabolism and Gene Expression in Adipocytes* 210 , 2001, The Journal of Biological Chemistry.

[32]  B. Ljung,et al.  Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. , 2001, Diabetes.

[33]  L. Pénicaud,et al.  Altered macrophage‐like functions of preadipocytes in inflammation and genetic obesity , 2001, Journal of cellular physiology.

[34]  C. Bogardus,et al.  Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians. , 2001, Molecular genetics and metabolism.

[35]  A. Rissanen,et al.  Weight change and blood coagulability and fibrinolysis in healthy obese women , 2001, International Journal of Obesity.

[36]  C. Bogardus,et al.  Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance , 2000, Diabetologia.

[37]  M. Clark,et al.  Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. , 2000, Diabetes.

[38]  E. Tai,et al.  Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin , 2000, International Journal of Obesity.

[39]  N. Socci,et al.  Leptin-specific patterns of gene expression in white adipose tissue. , 2000, Genes & development.

[40]  W. Scherbaum,et al.  Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. , 2000, Diabetes.

[41]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[42]  N. Van Rooijen,et al.  Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. , 1999, Investigative ophthalmology & visual science.

[43]  M. Petroni,et al.  Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors , 1999, International Journal of Obesity.

[44]  R. Leibel,et al.  The role of leptin in human physiology. , 1999, The New England journal of medicine.

[45]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[46]  L. DiPietro,et al.  Excess abdominal adiposity remains correlated with altered lipid concentrations in healthy older women , 1999, International Journal of Obesity.

[47]  C. Dani,et al.  A role for preadipocytes as macrophage‐like cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  S. Gordon.  The role of the macrophage in immune regulation. , 1998, Research in immunology.

[49]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[50]  D. Loskutoff,et al.  Tissue factor gene expression in the adipose tissues of obese mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Levine,et al.  Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. , 1998, The Journal of clinical investigation.

[52]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[53]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[54]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[55]  W. Chung,et al.  The Molecular Genetics of Rodent Single Gene Obesities* , 1997, The Journal of Biological Chemistry.

[56]  Robert V Farese,et al.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.

[57]  A. Marette,et al.  Expression of Nitric Oxide Synthase in Skeletal Muscle: A Novel Role for Nitric Oxide as a Modulator of Insulin Action , 1997, Diabetes.

[58]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[59]  D. Papanicolaou,et al.  Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. , 1997, The Journal of clinical endocrinology and metabolism.

[60]  F. Pixley,et al.  Biology and action of colony‐stimulating factor‐1 , 1997, Molecular reproduction and development.

[61]  I. Adamson,et al.  Alveolar macrophage kinetics and multinucleated giant cell formation after lung injury , 1996, Journal of leukocyte biology.

[62]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[63]  B. Lowell,et al.  Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. , 1995, The Journal of clinical investigation.

[64]  J. Friedman,et al.  Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[65]  K. Feingold,et al.  Interleukin-6 stimulates hepatic triglyceride secretion in rats. , 1995, Endocrinology.

[66]  R. Leibel,et al.  Changes in energy expenditure resulting from altered body weight. , 1995, The New England journal of medicine.

[67]  J. Pollard,et al.  Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. , 1994, Development.

[68]  B. Spiegelman,et al.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[69]  B. Spiegelman,et al.  Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. , 1993, Genes & development.

[70]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[71]  R. Woychik,et al.  Molecular characterization of the mouse agouti locus , 1992, Cell.

[72]  N. Athanasou,et al.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. , 1990, Journal of clinical pathology.

[73]  W. Wiktor-Jedrzejczak,et al.  Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[75]  R. Cortese,et al.  Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. , 1988, The Journal of biological chemistry.

[76]  B. Zinman,et al.  Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. , 1987, The Journal of clinical endocrinology and metabolism.

[77]  HELEN B. HUBERT,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[78]  I. Simpson,et al.  Mechanism of insulin-resistant glucose transport activity in the enlarged adipose cell of the aged, obese rat. , 1982, The Journal of clinical investigation.

[79]  J. Hirsch,et al.  Effects of altered adipose tissue morphology on plasma insulin levels in the rat. , 1981, American Journal of Physiology.

[80]  P. Björntorp,et al.  Body composition and adipose tissue cellularity before and after jejuno‐ileostomy in severely obese subjects , 1977, European journal of clinical investigation.

[81]  R. Geha,et al.  Clinical Immunology , 1972, The Lancet.

[82]  J. Hirsch,et al.  Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. , 1972, Lancet.

[83]  J. Dougherty,et al.  The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. , 1971, The Journal of clinical investigation.

[84]  Bradley Rd.  NECROSIS OF THE ANTERIOR PITUITARY AND ZONA GLOMERULOSA OF THE ADRENAL. , 1964 .

[85]  M. Heo,et al.  Determinants of leptin gene expression in fat depots of lean mice. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[86]  M. Washington,et al.  Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. , 2002, American journal of respiratory cell and molecular biology.

[87]  Chih‐Hao Lee,et al.  Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis. , 2002, Trends in endocrinology and metabolism: TEM.

[88]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[89]  R. Cone,et al.  Genetic models of obesity and energy balance in the mouse. , 2000, Annual review of genetics.

[90]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[91]  B. Seed,et al.  PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. , 1998, Nature.

[92]  D. Loskutoff,et al.  Elevated Expression of Transforming Growth Factor-β in Adipose Tissue from Obese Mice , 1997, Molecular medicine.

[93]  D. Loskutoff,et al.  Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. , 1996, The Journal of clinical investigation.

[94]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[95]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[96]  F. Dunn,et al.  Obesity and essential hypertension. , 1982, Contributions to nephrology.

[97]  F. Messerli,et al.  Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. , 1981, Archives of internal medicine.

[98]  W. J. Langford.  Statistical Methods , 1959, Nature.